National Institutes of Health Invests Heavily in Domestic Biomanufacturing and Pandemic Preparedness Infrastructure
The National Institutes of Health has announced a substantial grant program dedicated to constructing advanced domestic biomanufacturing facilities and securing critical pharmaceutical supply chains to protect the United States against future biological health emergencies.